Published in Life Science Leader, CRA’s Robert Broadnax, Eddie Li and Brian Carpenter co-authored an article “Know Your Customer: Strategic Considerations for AI-Powered Provider Segmentation,” focused on the strategic considerations for drug manufacturers in developing an AI-powered provider segmentation.
Advances in drug discovery and clinical development highlight the importance of understanding one’s healthcare provider (HCP) customer base for a given therapy and how to effectively engage with the customer to achieve maximum commercial success. Segmentation is a strategic exercise in which the customer base is divided into distinct groups of HCPs with similar needs, characteristics, demographics, behaviors, attitudes, and underlying motivations, and serves as the cornerstone for promotional targeting and engagement to customers.
